Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts

Despite the availability of different therapeutic modalities, treatment of recalcitrant common warts is still challenging. Cervarix, a recombinant bivalent human papillomavirus (HPV) vaccine, has shown promising efficacy in the treatment of warts.

Source: Journal of the American Academy of Dermatology - July 28, 2019 Category: Dermatology Authors: Ahmad Nofal, Ayman Marei, Al-shimaa M. Ibrahim, Eman Nofal, Manal Nabil Source Type: research